---
ontology: mondo
issue_number: 10149
pr_number: 10156
eval_repo_pr: 697
agent: std_opencode_g54
model: gpt-5.4
runtime: opencode
agent_config_tag: v3
case_type: new_term
difficulty: medium
f1: 0.455
precision: 0.417
recall: 0.500
jaccard: 0.294
outcome: success
failure_modes: []
case_quality: poor
case_quality_reason: placeholder_id_artifact_plus_gold_out_of_scope
scoring_caveat: "F1 systematically under-represents quality for every attempt: (1) placeholder MONDO:7770018 vs canonical gold MONDO:0700328 ID artifact; (2) gold PR #10156 exceeds issue #10149 scope (third child MONDO:0005376, equivalence axiom over CL:0000653, SCTID xref, per-child IAO:0000233). Judge against the issue's explicit asks."
reviewed_by: claude-opus-4.7
reviewed_at: 2026-05-17
---

## Summary

The gpt-5.4/opencode agent created `podocytopathy` as a new grouping term under
`MONDO:0019722 glomerular disorder` and added it as an additional (parent-preserving)
`is_a` to both children explicitly named in issue #10149 — `MONDO:0006835` lipoid
nephrosis / minimal change disease (the `@@ -149500` hunk) and `MONDO:0100313` focal
segmental glomerulosclerosis (the `@@ -583507` hunk). Against the issue's actual request
this is a complete and correct solution; graded **success**. The metadiff F1=0.455
materially **under-represents** quality and is capped by the established poor-case
artifacts (placeholder `MONDO:7770018` vs canonical gold `MONDO:0700328`, and the gold
PR exceeding issue scope). The prior codex stub graded this `partial_success` /
`under_editing` / `missed_requirement` — that is incorrect: both requested children are
present, so there is no missed requirement against the issue.

## Strengths

- Correct ontological substance: new term placed under the issue-requested parent
  `MONDO:0019722`, marked `subset: disease_grouping`, definition built from the
  issue-supplied PMIDs (PMID:25684864, PMID:32792490, PMID:38804512), ORCID
  `0009-0009-0876-0331` as `dcterms:creator`, and `IAO:0000233` issue tracker link.
- Both issue-requested children added as **additional** `is_a` axioms preserving the
  pre-existing parents (`MONDO:0002462 glomerulonephritis` on lipoid nephrosis,
  `MONDO:0000490 glomerulosclerosis` on FSGS) — the safe, correct reclassification
  pattern, matching the gold's additive approach.
- Tightly scoped: a single new `[Term]` stanza plus two one-line `is_a` additions, no
  collateral edits, no deletions. Precisely the issue request, nothing more.
- PR write-up documents reading `__issue_context__.json`, PMID verification via PubMed
  (aurelian unavailable), parent/child existence checks, temp-ID clash check, and
  `robot convert` syntax validation, honestly noting Docker/ODK NORM was unavailable.

## Issues

- No logical/equivalence definition (`intersection_of: MONDO:0019722` +
  `intersection_of: disease_has_location CL:0000653`), no third child
  `MONDO:0005376 membranous glomerulonephritis`, no `xref: SCTID:1367669003`, no
  per-child `property_value: IAO:0000233`. All of these are gold **enrichments beyond
  the issue text** — the issue asked only for the genus parent and exactly two children
  — so their absence is a scope-faithful divergence, not a failure or omission.
- Slightly leaner `source=` PMID provenance on the child `is_a` axioms than gold
  (e.g. lipoid nephrosis cites PMID:25684864/PMID:32792490 only). Normal metadiff
  under-representation; not a substantive error.
- Behaviorally identical to attempt pr752 (same blob `dc07fab`); noted for completeness.
